dextroamphetamine has been researched along with Intellectual Disability in 17 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thioridazine was variable across clients, settings, behaviors, and dosages." | 1.27 | Clinical behavioral pharmacology: methods for evaluating medications and contingency management. ( Burgio, LD; Capriotti, RM; Page, TJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (94.12) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, J | 1 |
| Perera, B | 1 |
| Shankar, R | 1 |
| FISH, CH | 1 |
| BOWLING, E | 1 |
| Abdou, FA | 1 |
| Aman, MG | 1 |
| Hollis, JH | 1 |
| Schain, RJ | 1 |
| Springer, NS | 1 |
| Fricke, NL | 1 |
| Payton, JB | 1 |
| Burkhart, JE | 1 |
| Hersen, M | 1 |
| Helsel, WJ | 1 |
| Burgio, LD | 1 |
| Page, TJ | 1 |
| Capriotti, RM | 1 |
| Campbell, M | 2 |
| Breuer, H | 1 |
| Wolman, SR | 1 |
| Livingston, S | 1 |
| Pauli, LL | 1 |
| Omenn, GS | 2 |
| Forman, MA | 1 |
| Hetznecker, W | 1 |
| Fish, B | 1 |
| David, R | 1 |
| Shapiro, T | 1 |
| Collins, P | 1 |
| Koh, C | 1 |
| Maas, JW | 1 |
| Dekirmenjian, H | 1 |
| Fawcett, JA | 1 |
| Anton, AH | 1 |
| Greer, M | 1 |
8 reviews available for dextroamphetamine and Intellectual Disability
| Article | Year |
|---|---|
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 2020 |
Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.
Topics: Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; | 1982 |
Minimal brain Dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Cerebral Palsy; Child; Child, Prescho | 1975 |
Nutrition and drug therapy for persons with developmental disabilities.
Topics: Anticonvulsants; Antidepressive Agents; Appetite; Dextroamphetamine; Drug-Related Side Effects and A | 1975 |
Genetic approaches to the syndrome of minimal brain dysfunction.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diseases in Tw | 1973 |
Child psychiatry.
Topics: Adolescent; Adoption; Child; Child Abuse; Child Behavior Disorders; Child Development; Child Psychia | 1972 |
MHPG excretion by patients with affective disorders.
Topics: Affective Symptoms; Bipolar Disorder; Brain; Catecholamines; Creatinine; Depression; Desipramine; De | 1974 |
Genetic issues in the syndrome of minimal brain dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Diseases in Twins; Female; Humans; | 1973 |
2 trials available for dextroamphetamine and Intellectual Disability
| Article | Year |
|---|---|
Treatment of ADDH in mentally retarded children: a preliminary study.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Clinical Trials as Topic; Co | 1989 |
Liothyronine treatment in psychotic and nonpsychotic children under 6 years.
Topics: Age Factors; Brain Damage, Chronic; Child; Child Behavior Disorders; Child, Preschool; Clinical Tria | 1973 |
7 other studies available for dextroamphetamine and Intellectual Disability
| Article | Year |
|---|---|
Effect of amphetamines on speech defects in the mentally retarded.
Topics: Amphetamine; Aphasia; Cleft Palate; Deafness; Dextroamphetamine; Double-Blind Method; Humans; Intell | 1962 |
Psychotropic drug therapy in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Child Behavior Disorders; Chlorpromazine; Dextroamphetamin | 1967 |
Analysis of rocking behavior.
Topics: Acoustic Stimulation; Adolescent; Animals; Behavior; Child; Chlorpromazine; Conditioning, Operant; D | 1978 |
Clinical behavioral pharmacology: methods for evaluating medications and contingency management.
Topics: Achievement; Adult; Aggression; Attention; Behavior Therapy; Child; Dextroamphetamine; Humans; Intel | 1985 |
The interplay of biological and environmental factors in a preschool-age patient with Klinefelter's syndrome. Case report.
Topics: Abnormalities, Drug-Induced; Amobarbital; Child Behavior Disorders; Child, Preschool; Dermatoglyphic | 1973 |
Letter: 'West syndrome'.
Topics: Anti-Anxiety Agents; Benzodiazepines; Dextroamphetamine; Dietary Fats; Humans; Infant; Intellectual | 1974 |
Dextroamphetamine, catecholamines, and behavior. The effect of dextroamphetamine in retarded children.
Topics: Catecholamines; Child; Child Behavior Disorders; Dextroamphetamine; Dopamine; Epinephrine; Humans; H | 1969 |